APA (7th ed.) Citation

K, E., K, D., C, B., O, N., E, T. J., G, W., . . . P, S. (2017). DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors. Neuroendocrinology, 105(2), 170. https://doi.org/10.1159/000452891

Chicago Style (17th ed.) Citation

K, Edfeldt, Daskalakis K, Bäcklin C, Norlén O, Tiensuu Janson E, Westin G, Hellman P, and Stålberg P. "DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors." Neuroendocrinology 105, no. 2 (2017): 170. https://doi.org/10.1159/000452891.

MLA (9th ed.) Citation

K, Edfeldt, et al. "DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors." Neuroendocrinology, vol. 105, no. 2, 2017, p. 170, https://doi.org/10.1159/000452891.